Mackenzie Financial Corp Grows Stock Position in Danaher Co. (NYSE:DHR)

Mackenzie Financial Corp boosted its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 47.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,666,144 shares of the conglomerate's stock after acquiring an additional 534,335 shares during the quarter. Mackenzie Financial Corp owned 0.23% of Danaher worth $382,463,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Forum Financial Management LP boosted its holdings in Danaher by 38.5% during the 4th quarter. Forum Financial Management LP now owns 8,202 shares of the conglomerate's stock valued at $1,883,000 after acquiring an additional 2,282 shares during the period. Wormser Freres Gestion boosted its holdings in Danaher by 14.5% during the 4th quarter. Wormser Freres Gestion now owns 5,128 shares of the conglomerate's stock valued at $1,211,000 after acquiring an additional 650 shares during the period. Warm Springs Advisors Inc. purchased a new stake in shares of Danaher in the 4th quarter worth $438,000. North Star Asset Management Inc. lifted its holdings in shares of Danaher by 3.7% in the 4th quarter. North Star Asset Management Inc. now owns 109,465 shares of the conglomerate's stock worth $25,128,000 after buying an additional 3,896 shares during the period. Finally, GF Fund Management CO. LTD. purchased a new stake in shares of Danaher in the 4th quarter worth $3,680,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Guggenheim reiterated a "buy" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. HSBC lowered their target price on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Wells Fargo & Company lowered their target price on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. Finally, Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research note on Friday, March 14th. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $263.24.

Danaher Stock Performance

Shares of DHR stock traded up $1.03 during mid-day trading on Thursday, reaching $190.04. The stock had a trading volume of 1,215,619 shares, compared to its average volume of 3,464,748. The business's fifty day moving average is $193.63 and its 200-day moving average is $214.49. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market cap of $136.01 billion, a price-to-earnings ratio of 36.00, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.67%. Danaher's dividend payout ratio (DPR) is 24.85%.

Insider Buying and Selling

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.20% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.